Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research...
Read more
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge...
Read more
GSK and the Sabin Vaccine Institute announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines...
Read more
Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing...
Read more
Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed...
Read more
AstraZeneca and Merck presented full results from the Phase 3 SOLO3 trial which evaluated LYNPARZA, compared to chemotherapy, for the...
Read more
ProtoKinetix, announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction...
Read more
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today...
Read more
Bioclinica® has assembled a team of experts dedicated to nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic...
Read more
SGS will implement the Veeva Vault CTMS (clinical trial management system) across its network of clinical operations sites for the...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
